Doktor axborotnomasi 2024, №4 (116)

Тема статьи

HCV ETIOLOGIYALI JIGAR SIRROZIDA ANTIVIRUS TERAPIYA NEGIZIDA MIELOGRAMMA XUSUSIYATLARI (54-59)

Авторы

N. F. Nuriddinova

Учреждение

Toshkent tibbiyot akademiyasi, Toshkent, O‘zbekiston

Аннотация

Jahon sog‘liqni saqlash tashkilotining ma’lumotlariga ko‘ra, dunyoda taxminan 325 mln. odam parenteral gepa tit viruslari bilan zararlangan bo‘lib, 500 mln. dan ko‘p insonlar klinikasiz virus tashuvchanlikka ega. 2015 – yilda virusli gepatit tufayli 1,34 mln. o‘lim holati kuzatilgan. Gemostaz tizimi fiziologiyasi jigar faoliyati bilan bevosita bog‘liq, chunki gepatotsitlar ko‘plab koagulyatsion omillar, antikoagulyant oqsillar, fibrinoliz tizimi komponentlari va trombopoezni stimullovchi omillarni ishlab chiqaradi. Surunkali diffuz jigar kasalliklari bilan kasallangan bemorlarda qizilo‘ngach varikoz kengaygan venalaridan qon ketishi, gematomalar, gemorragik purpura, burun va milk qonashi, menorragiyalar kabi asoratlar kuzatilishi hozirgacha dolzarb klinik muammo bo‘lib qolmoqda. Maqsad: HCV eti ologiyali jigar sirrozida antivirus terapiya fonida mielogramma ko‘rsatkichlarining laborator diagnostikasini baholash. Ma’lumotlar 2020-2023 yillarda Toshkent tibbiyot akademiyasi 1-klinikasi gematologiya va gepatobiliar patologiyasi bo‘limlarida HCV etiologiyali surunkali gepatit bilan davolangan bemorlardan olindi.

Ключевые слова

jigar sirrozi, megakariotsit, suyak ko‘migi, trombotsit.

Литературы

1. Bulatova I.A. Functional state of the endothelium and its diagnostic significance in assessing the severity of chron ic diffuse liver diseases: abstract of thesis. Candidate of Medical Sciences. – Ekaterinburg, 2009. – 17 p. 2. Bilalova A.R. Features of the clinic and hemostasis system in patients with chronic hepatitis and cirrhosis of the liver: abstract of thesis. Candidate of Medical Sciences - Moscow, 2015. - 24 p. 3. Babadjanova Sh.A., Zaynutdinova D.L. Frequency and characteristics of immune thrombocytopenia at different stages of pregnancy // Nazariy va klinik tibbiyot jurnali. 2021. №5. B. 9-12. ISSN 2091-5853 4. Batirova A.S., Bakanov M.I., Surkov A.N. The modern concepts of hemostasis system under Chronic diseases of liver: the publication review //Klin.Lab.Diagn.–2015.–Vol.60(8), P.40–44. 5. Bienholz A., Canbay A., Saner F.H. Coagulation management in patients with liver disease // Med.Klin.Intensivmed Notfmed.–2016.–Vol.111(3),–P.224–234. 6. Caldwell S.H., Hoffman M., Lisman T.et al. Coagulation disorders and hemostasis in liver disease: pathophysiolo gy and critical assessment of current management //Hepatology.–2006.–Vol.44.–P.44. 7. Francoz C., Belghiti J., Vilgrain V. et al. Splanchnic vein thrombosis in candidates for liver transplantation: useful ness of screening and anticoagulation //Gut.–2005.Vol.54(5),–P.691–697. 8. Ghumlas A.K., Abdel Gader A.G., Al Faleh F.Z. Haemostatic abnormalities in liver disease: could some haemo static tests be useful as liver function tests? //Blood Coagul Fibrinolysis.–2005.–Vol.16(5),–P.329–335 9. Hartmann M., Cynthia S., Fuat H. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treat ment //World Journal of Gastroenterology.–2016.–Vol.22(4).–P.1541–1550. 10. Hollestelle M.J., Geertzen H.G.M., Straatsburg I.H., van Gulik T.M., van Mourik J.A. Factor VIII expression in liver disease //Thromb Haemost.–2004.–Vol.91,–P.267–275. 11. Huard G., Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: A systematic review //Int.J.Hepatol.–2012.–Vol.2012,–P.6–7. 12. Iancu R.I., Iancu D., Murărescu D., Nechifor M., Costuleanu M. Platelet functions in acute and chronic experimen tally induced hepatopathia //Rev.Med.Chir.Soc.Med.Nat.Iasi.–2010.–Vol.114(4).–P.1101–1106. 13. Kurbonova Z.C., Babadjanova S.A., Islamova Z.S., Musayeva N.B., Babadjanov A.S.(2020). Some features of hemorrhagic syndrome in chronic diffuse liver diseases. Indian Journal of Forensic Medicine and Toxicology, 14 (4), 7443-7448. 14. Kurokawa T., Ohkohchi N. Platelets in liver disease, cancer and regeneration //World J.Gastroenterol.–2017. Vol.23(18),–P.3228–3239. 15. Pavlov Ch.S., Shulpekova Yu.O., Zolotarevsky V.B., Kogan E.A., Ivashkin V.T. Modern methods for early diag nosis of liver fibrosis // Clinical Medicine. – 2005. – No. 12. – P. 58–60. 16. Serov V.V., Bushueva N.V., Ignatova T.M., Aprosina Z.G. Viral and host factors in the development and progres sion of chronic viral hepatitis C and B //Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2006.–No. 4.–P.12–23.